Navigation Links
Free CME-certified Webcast: Making Your Case: Up-to-date Answers for Developing Trends in PCI
Date:10/19/2007

WASHINGTON, Oct. 19 /PRNewswire/ -- Interventional cardiologists operate in an environment of great flux, and as such face many challenges in the provision of optimal patient care. New devices, continuing debate over the use of drug-eluting versus bare metal stents, and evolving procedures involved in peripheral intervention are among these changes. Further, recently released ACC/AHA guidelines for the management of UA/NSTEMI patients, and soon-to-be released guidelines for the management of STEMI patients, issue revised recommendations concerning adjuvant pharmacotherapy for percutaneous coronary intervention (PCI) that will greatly impact clinical practice.

The free CME-certified Web cast, Making Your Case: Up-to-date Answers for Developing Trends in PCI aims to bridge the gap between evidence and patient care by assisting interventional cardiologists in translating guidelines into practice. The most recent evidence-based approaches for acute coronary syndrome (ACS) management will be presented by cardiology experts: C. Michael Gibson, MD; Ehtisham Mahmud, MD; Eric Peterson, MD, MPH; and Steven Steinhubl, MD. An interactive case-based discussion will follow and will highlight real world challenges and how to approach them.

The program will be presented on October 21, 2007, from 8:00 PM to 10:00 PM EDT. Broadcast live during the Transcatheter Cardiovascular Therapeutics annual meeting, this innovative, case-based symposium will provide interventional cardiologists and other clinicians with detailed information on treating patients with ACS. Those participating in the Web cast also have the opportunity to take part in the interactive ARS questions during the program. This activity is sponsored by INNOVIA Education Institute and supported by and educational grant from sanofi-aventis, U.S.

TITLE: Making Your Case: Up-to-date Answers for Developing Trends in PCI

FACULTY: C. Michael Gibson, MD; Ehtisham Mahmud, MD; Eric Peterson, MD,

MPH; and Steven Steinhubl, MD

WHEN: Sunday, October 21,2007; 8:00 PM-10:00 PM EDT

WHERE: http://www.iian.ibeam.com/events/mult001/24118/

HOW: Live over the Internet-simply log on to the above web site. The

CME- certified Webcast will be archived shortly after the live

presentation and made available for download for 1 year.

CREDIT HOURS: INNOVIA Education Institute designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

LEARNING OBJECTIVES

As a result of participating in this symposium, learners will be able to:

-- Review recent trends and challenges in PCI

-- Understand the options for evidence-based adjuvant pharmacotherapy in

PCI

-- Better target evidence-based care and new treatment guidelines to

specific PCI patients

-- Eliminate barriers to evidence-based STEMI and NSTEMI care in one's own

practice

ABOUT INNOVIA EDUCATION INSTITUTE

INNOVIA Education Institute, LLC, the coordinator of this educational activity, has been an accredited provider of continuing medical education (CME) for physicians since 1988. Headquartered in Columbia, MD, INNOVIA Education Institute is dedicated to independent, science-based communications for health care product manufacturers and quality professional education with the goal of providing information to health care providers that ultimately improves patient care. Find out more information about INNOVIA at http://innoviaeducation.com.

CONTACT INFORMATION

For more information about the program, please contact Karen Gatzke at (410) 312-3548 or kgatzke@innoviaeducation.com.


'/>"/>
SOURCE INNOVIA Education Institute, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. New Tools for Making and Processing Protein Microarrays.
2. Making deals with evolving technologies in mind
3. Fusion 2007: Making the business case for technology
4. Making the transition from Web 2.0 to Web 2.007
5. 9 tips for making 90 seconds count in an investment pitch
6. Making sure YourSpace is technologically sound
7. Making Wisconsin the biotechnology leader
8. Mirus announces new method for making antibodies
9. Fusion 2006 symposium focuses on making IT work for businesses
10. Making RFID mainstream
11. Four steps to making talent management a core competence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):